Please login to the form below
Deloitte
This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.
Pfizer appoints David Denton as chief financial officer and executive vice president
Denton has held various leadership roles, including senior vice president and controller/chief accounting officer and has previously worked with the management consulting firm of Deloitte Touche Tohmatsu.
Latest news
-
The forefront of technology innovation
These are among Deloitte’s predictions for life sciences and the future for drugs companies and their operations, from The Future Awakens: Life Sciences and Health Care Predictions 2022 (Deloitte, November
-
Orphan drugs dominate FDA's record-breaking year
A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.
-
Pharma’s R&D productivity sinks to a new low
The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.
-
Artificial intelligence in healthcare
According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study
-
NHS bracing for 'no deal’ Brexit impact, including medicines
According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.
More from news
Approximately 2 fully matching, plus 18 partially matching documents found.
Latest Intelligence
-
Product launches: making the most of your one shot
A recent analysis by Deloitte showed that most new drugs continue with the revenue trajectory set at launch – around 70% of products that miss expectations at launch continue doing so in
-
The new reality of building a corporate brand in pharma
According to Deloitte Insight’s 2021 Global Marketing Trends report, purpose is one of the key aspects necessary for businesses to flourish – they need to understand why they exist and who ... According to a 2019/20 Deloitte survey, 68% of biopharma
-
Successful product commercialisation: what can we learn from the rare disease setting?
Rare diseases: setting the gold standard for successful product launches. A recent Deloitte Insights white paper found that three product characteristics are strongly associated with strong launch performance: priority review and
-
Emerging use cases of blockchain in healthcare and the life sciences
The Prescrypt project, spearheaded by Deloitte in the Netherlands, is pursuing a completely different focus by working to put patients’ drug prescriptions on the blockchain for secure communication, usage tracking and
-
Start small but think big
Deloitte’s Future of Work initiative highlights the increasingly important role that contractors, freelancers and external experts play in building the flexible and agile teams that companies need.
More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest appointments
-
New hires at Bristol-Myers Squibb, Acceleron and FerGene
Prior to that, she held several senior communications roles, including chief communications officer at Deloitte, as well as senior roles at Novartis, Pfizer and leadership roles at biotech and healthcare communications
-
Paul Stockdale joins Oxford BioDynamics as CFO
Stockdale arrives at the company from e-Therapeutics, where he had been financial controller since 2012, and has also previously served at Deloitte as a senior manager.
-
AlixPartners appoints new managing director
Previously healthcare and life sciences partner at Deloitte Consulting, Vogt has experience advising companies in the medtech, healthcare and pharmaceutical industries in implementing and improving strategies. ... Prior to his experience at Deloitte
-
Sanofi appoints Diane Souza and Thomas Südhof
Prior to this, Souza held the role of chief financial officer at Aetna, overseeing its guaranteed products business, and has also held senior leadership positions at Deloitte and PriceWaterhouseCooper.
-
Quantum Pharma promotes Chris Rigg to chief financial officer
He brings 20 years of financial and managerial experience to the role, having worked at Deloitte, Eaga, PriceWaterhouseCoopers and Barclays, where he headed up its North East corporate banking division.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Genesis Research Acquires Market Access Transformation
Advisors. Genesis Research was advised on the transaction by Clearview Healthcare Partners, Deloitte, Palo Alto, Piper Sandler and Ropes &Gray.
-
GHO Capital Acquires Genesis Research
Ropes &Gray acted as legal advisor to GHO; CIL as commercial advisor; Alvarez and Marsal as financial advisor; Deloitte LLP as tax advisor and CRS as insurance advisor.
-
Remote Patient Monitoring
The COVID-19 pandemic has brought into sharp focus the need to harness and leverage digital tools and technology for remote patient monitoring (RPM). With the onset of lockdown, and a sense of unease when visiting conventional clinical settings,
-
Impetus Digital Fireside Chat with Deloitte Europe: The Future of Learning
Ladana Edwards, Partner at Deloitte Central Europe and Thomas de Bruyne, Consultant with Deloitte Belgium, share their thoughts on the future of education and the role of digital technologies such as
-
From nature to art galleries: thinking differently about healthcare
Deloitte, 2019.Last accessed February 2020, available at: ). Accenture, 2019. Last accessed February 2020, available at: . Public Health England. Last accessed February 2020, available at: . 44 (0) 20 7009 3100. Address:.
More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns
- WHO releases interim statement on COVID-19 vaccination for children and adolescents
- Novartis reports death of two patients treated with Zolgensma
- The impact of COVID-19 on the fight against AMR
- NHS bowel cancer checks reach record-high following death of Dame Deborah James
- Environment: where does the pharmaceutical industry stand?
- Moderna’s Omicron booster receives MHRA approval
- Sanofi halts recruitment for trials assessing MS treatment
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- A creative awakening – how pharma is bringing innovation to the patient journey
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
PMHub
Thrive Agency
We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
